Skip to content
Back to event

KalshiKalshi· Financials

What will the FDA's decision be on Ifinatamab Deruxtecan by Daiichi Sankyo in 2026?

Chance

87%

Buy Yes

98¢

pays $1 if it happens

Buy No

24¢

pays $1 if it doesn’t

Prices from Kalshi, updated 14 minutes ago. Ends Jan 1, 4:59 AM UTC.

Price over the last 2 weeks
Cost of a Yes share

Latest trades

  • 41 minutes agoSold yes at 93¢$52
  • 41 minutes agoSold yes at 88¢$440
  • 41 minutes agoSold yes at 87¢$4
  • yesterdaySold yes at 81¢$8
  • yesterdaySold yes at 98¢$49
  • yesterdaySold yes at 98¢$27
  • yesterdaySold yes at 82¢$410